Antiobesity effects of the novel in vivo neutral cannabinoid receptor antagonist 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-3-hexyl-1H-1,2,4-triazole - LH 21

1. Pavon, F.J.
2. Bilbao, A.
3. Hernández-Folgado, L.
4. Cippitelli, A.
5. Jagerovic, N.
6. Abellán, G.
7. Rodríguez-Franco, M.I.
8. Serrano, A.
9. Macias, M.
10. Gómez, R.
11. Navarro, M.
12. Goya, P.
13. Rodríguez de Fonseca, F.